Papers/PMID:20022616
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
Metabolism: clinical and experimental2010The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
chromium(3+) — no detected effect on fasting blood glucose
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“In the entire cohort, differences between placebo and Cr groups for A1c (Δ = 0.12 %) and fasting glucose (Δ = 5.4 mg/dl) were not felt to be statistically significant.”
Quoted verbatim from Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.. - Study
- RCT
- Duration
- 6 months
- Dose
- 1000 ug Cr daily as chromium picolinate (two 500 ug tablets)
- Population
- Adults aged 30-70 with type 2 diabetes, BMI 25-40, whole randomised cohort (not the insulin-sensitivity responder subgroup); 24 weeks of chromium picolinate versus placebo
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.2010PMID:20022616Permalink